So, so many companies have been caught promoting drugs &quot;off-label&quot;, for uses that the FDA hasn&#x27;t approved. So many. Johnson &amp; Johnson paid $1.4 BILLION to settle a suit alleging that they heavily promoted the use of antipsychotics on dementia patients.<p><a href="https:&#x2F;&#x2F;en.wikipedia.org&#x2F;wiki&#x2F;List_of_off-label_promotion_pharmaceutical_settlements" rel="nofollow">https:&#x2F;&#x2F;en.wikipedia.org&#x2F;wiki&#x2F;List_of_off-label_promotion_ph...</a>